TRANSCRIPTION factors of the NFAT family regulate the production of ef
fector proteins that coordinate the immune response(1). The immunosupp
ressive drugs FK506 and cyclosporin A (CsA) act by blocking a Ca2+-med
iated signalling pathway leading to NFAT. Although FK506 and CsA have
enabled human organs to Re transplanted routinely, the toxic side-effe
cts of these drugs limit their usage. This toxicity might be absent in
antagonists that target NFAT directly. As a first step in the structu
re-based search for NFAT antagonists, we now report the identification
and solution structure of a 20K domain of NFATc (NFATc-DBD) that is b
oth necessary and sufficient to bind DNA and activate transcription co
operatively. Although the overall fold of the NFATc DNA-hinding domain
is related to that of NF-kappa B p50 (refs 2, 3), the two proteins us
e significantly different strategies for DNA recognition. On the basis
of these results, we present a model for the cooperative complex form
ed between NFAT and the mitogenic transcription factor AP-1 on the int
erleukin-2 enhancer.